BEUDAMED
    1,392 results · 25ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

    FDA classification
    FDA Class 2 ·Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

    Antigen, Invasive Fungal Pathogens

    FDA classification
    FDA Class 2 ·Antigen, Invasive Fungal Pathogens

    Medication Management System, Remote

    FDA classification
    FDA Class 2 ·Medication Management System, Remote

    System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

    FDA classification
    FDA Class 2 ·System, Microarray-Based, Genome-Wide, Postnatal Chromosomal Abnormality Detection

    Kit, Conception-Assist, Home Use

    FDA classification
    FDA Class 2 ·Kit, Conception-Assist, Home Use

    Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    FDA classification
    FDA Class 2 ·Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents

    Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm

    FDA classification
    FDA Class 2 ·Digital Cervical Cytology Slide Imaging System With Artificial Intelligence Algorithm

    Cancer Predisposition Risk Assessment System

    FDA classification
    FDA Class 2 ·Cancer Predisposition Risk Assessment System

    Respiratory Virus Panel Nucleic Acid Assay System

    FDA classification
    FDA Class 2 ·Respiratory Virus Panel Nucleic Acid Assay System

    Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings

    Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    FDA classification
    FDA Class 2 ·Simple Point-Of-Care Device To Detect Sar-Cov-2 Nucleic Acid Targets From Clinical Specimens In Near-Patient Settings

    System, Test, Radioallergosorbent (Rast) Immunological, Exempt Allergens

    FDA classification
    FDA Class 2 ·System, Test, Radioallergosorbent (Rast) Immunological, Exempt Allergens